We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

162 hedge funds and large institutions have $296M invested in Niagen Bioscience in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 38 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $1.03M

79% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 38

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

5% more funds holding

Funds holding: 155 → 162 (+7)

2.97% more ownership

Funds ownership: 36.84% → 39.8% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

29% less capital invested

Capital invested by funds: $418M → $296M (-$122M)

Holders
162
Holders Change
+7
Holders Change %
+4.52%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
68
Reduced
38
Closed
24
Calls
$1.9M
Puts
$1.03M
Net Calls
+$869K
Net Calls Change
+$546K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$11.2M
2
Millennium Management
Millennium Management
New York
+$6.59M
3
AG
Algert Global
California
+$4.51M
4
Charles Schwab
Charles Schwab
California
+$4.19M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.87M

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$10.7M
2
WCM
Woodson Capital Management
Connecticut
-$7.21M
3
Invesco
Invesco
Georgia
-$4.37M
4
JF
Jump Financial
Illinois
-$3.44M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
26
Hillsdale Investment Management
Ontario, Canada
$2.99M +$37.4K +3,700 +1%
Raymond James Financial
27
Raymond James Financial
Florida
$2.97M +$98.1K +9,711 +3%
EI
28
EAM Investors
California
$2.4M -$1.4M -138,743 -35%
State of Wisconsin Investment Board
29
State of Wisconsin Investment Board
Wisconsin
$2.14M +$758K +75,065 +49%
Los Angeles Capital Management
30
Los Angeles Capital Management
California
$2.03M +$1.75M +173,235 +386%
Citadel Advisors
31
Citadel Advisors
Florida
$1.86M +$2.01M +199,303 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.83M +$121K +11,995 +7%
DFCM
33
Dark Forest Capital Management
Puerto Rico
$1.77M +$1.4M +138,752 +270%
NA
34
Navellier & Associates
Nevada
$1.77M +$378K +37,461 +25%
GF
35
Gabelli Funds
New York
$1.75M -$24.2K -2,400 -1%
Prudential Financial
36
Prudential Financial
New Jersey
$1.71M +$504K +49,889 +37%
PAM
37
Panagora Asset Management
Massachusetts
$1.61M +$1.48M +146,684 +576%
PWS
38
Precision Wealth Strategies
Missouri
$1.53M +$619K +61,311 +60%
Jane Street
39
Jane Street
New York
$1.47M +$841K +83,291 +111%
AllianceBernstein
40
AllianceBernstein
Tennessee
$1.39M +$997K +98,770 +196%
American Century Companies
41
American Century Companies
Missouri
$1.27M +$408K +40,367 +42%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$1.19M +$560K +55,501 +77%
GI
43
GAMCO Investors
Connecticut
$1.17M -$33.8K -3,350 -3%
SBCM
44
Silverberg Bernstein Capital Management
New York
$1.17M +$260K +25,786 +26%
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$1.17M – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$997K +$1.08M +106,900 New
HSA
47
Hussman Strategic Advisors
Maryland
$980K +$1.06M +105,000 New
Franklin Resources
48
Franklin Resources
California
$947K +$446K +44,174 +77%
DSCM
49
Divisadero Street Capital Management
Florida
$933K +$1.01M +100,000 New
BCM
50
Bridgeway Capital Management
Texas
$860K – – –
1
2
3 4 5

NAGE Hedge Fund Activity: Q3 2025 in Review

162 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2025, worth a combined $296M — down 29% from $418M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NAGE positions and 24 closed out — a net gain of 8 holders — while 68 added to existing stakes and 38 trimmed.

The largest buyer was UBS Group, adding an estimated $11.2M. The largest seller was D.E. Shaw & Co, cutting an estimated $10.7M.

  • 162 institutional investors held Niagen Bioscience (NAGE) as of Q3 2025, up from 155 in Q2 2025.
  • Funds reported $296M of Niagen Bioscience stock for Q3 2025, down 29% quarter-over-quarter.
  • 32 funds opened new Niagen Bioscience positions in Q3 2025 and 24 closed out, a net change of +8 holders.
  • The largest Niagen Bioscience buyer in Q3 2025 was UBS Group, an estimated $11.2M added.
  • The largest Niagen Bioscience seller in Q3 2025 was D.E. Shaw & Co, an estimated $10.7M sold.

Based on aggregated 13F filings for Q3 2025.